JPRN-UMIN000030865招募中未知
Intervention study of autoimmune bullous disease with imatinib - Treatment of autoimmune bullous disease with imatinib
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) There is a history that has allergy to Imatinib. 2) It has one of the following complications. Serious heart disease or its past liver disorder, renal disorder 3) Consent Acknowledging participation in other exams within 4 weeks before acquisition. 4) In addition, patients judged unsuitable for the trial responsible doctor or shared medical doctor to safely carry out this study.
研究者
相似试验
已完成
1 期
Imatinib treatment of autoimmune bullous diseasesAutoimmune bullous disease including pemphigus group and pemphigoid groupD012872JPRN-jRCTs051180069Kabashima Kenji12
已完成
不适用
Study for prevention of autoimmune non-insulin-dependent diabetes mellitus with sitagliptin (SPAN-S)Diabetes mellitus (GAD Ab positive non-insulin dependent diabetes mellitus)JPRN-UMIN000003693Saitama Medical University80
招募中
不适用
Pathophysiological study for autoimmune dysregulation of hereditary angioedemaHereditary angioedemaJPRN-UMIN000010754Juntendo Hospital50
尚未招募
不适用
Efficacy of B cell-targeted therapy in autoimmune bullous diseasesNL-OMON51059niversitair Medisch Centrum Groningen200
进行中（未招募）
1 期
Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB)Myasthenia Gravis Systemic Lupus ErythematosusRheumatoid ArthritisEUCTR2013-005362-19-DECharité - Universitätsmedizin Berlin18